Relative adrenal insufficiency in non-critically ill liver cirrhosis

Read full text Summarise with VIRAT
Authors: Dipen Agarwal, G. Vamshi Nandan Rao, Viswanath Reddy Donapati, B. Ravi Shankar
Cited by: 0
References: 26

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Endocrinopathy like adrenal insufficiency (AI) is being increasingly recognised in patients with liver cirrhosis. It is characterized by a relative decrease in serum cortisol level with respect to increasing stress as occurs in sepsis & has been associated with increased morbidity and mortality. This study aimed to find the prevalence of Adrenal insufficiency and low HDL in non-critically ill chronic liver disease (CLD) patients i.e. patients without sepsis, bleed or dehydration. Methodology: A cross-sectional study including 100 non-critically ill CLD patients aged 20 -80 years. Model for end stage liver disease (MELD) scores and the Child Turcotte Pugh scores (CTP) were used to assess the severity of liver disease. Basal cortisol level was measured & after one hour of short synacthen test (SST), peak and delta cortisol levels were measured in order to assess adrenal function. Biochemical parameters including HDL levels were also assayed. Results: This study included 76 male and 24 female CLD patients. Prevalence of AI was highest in females of age 41-60 years. Alcohol (61%) was the most common etiology, followed by MASLD and HBV. Prevalence of AI was 55.6%, 60.5% and 65.9% in CTP class A, B and C respectively. Prevalence of AI in the high MELD (>15) group was 66.7% and 50% in the low MELD (

Fields of Study & Subjects

Adrenal Hormones and Disorders Liver Disease and Transplantation Electrolyte and hormonal disorders

Publication details

Journal / source
International Journal of Research in Medical Sciences
Volume
14
Issue
4
Pages
1555–1560
Publication date
30 March 2026
Language
EN